U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 16:52:41 GMT 2023
Edited
by admin
on Sat Dec 16 16:52:41 GMT 2023
Protein Type VIRAL STRUCTURAL PROTEIN
Protein Sub Type VIRAL ENVELOPE PROTEIN
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
8R39BE7TJJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SPIKE GLYCOPROTEIN (SARS-COV-2)
Common Name English
E2 (SARS-COV-2)
Common Name English
PEPLOMER PROTEIN (SARS-COV-2)
Common Name English
S GLYCOPROTEIN (SARS-COV-2)
Common Name English
Code System Code Type Description
FDA UNII
8R39BE7TJJ
Created by admin on Sat Dec 16 16:52:41 GMT 2023 , Edited by admin on Sat Dec 16 16:52:41 GMT 2023
PRIMARY
From To
1_1069 1_1113
3_1069 3_1113
2_1069 2_1113
1_1019 1_1030
3_1019 3_1030
2_1019 2_1030
1_827 1_838
3_827 3_838
2_827 2_838
1_730 1_736
3_730 3_736
2_730 2_736
1_725 1_747
3_725 3_747
2_725 2_747
1_649 1_658
3_649 3_658
2_649 2_658
1_604 1_636
3_604 3_636
2_604 2_636
1_525 1_577
3_525 3_577
2_525 2_577
1_467 1_475
3_467 3_475
2_467 2_475
1_378 1_512
3_378 3_512
2_378 2_512
1_366 1_419
3_366 3_419
2_366 2_419
1_323 1_348
3_323 3_348
2_323 2_348
1_278 1_288
3_278 3_288
2_278 2_288
1_118 1_153
3_118 3_153
2_118 2_153
1_2 1_123
3_2 3_123
2_2 2_123
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_4
N 1_48
N 1_61
N 1_109
N 1_136
N 1_152
N 1_221
N 1_269
N 1_318
N 1_330
N 1_590
N 1_603
N 1_644
N 1_696
N 1_704
N 1_788
N 1_1061
N 1_1085
N 1_1121
N 1_1145
N 1_1160
N 1_1181
N 2_4
N 2_48
N 2_61
N 2_109
N 2_136
N 2_152
N 2_221
N 2_269
N 2_318
N 2_330
N 2_590
N 2_603
N 2_644
N 2_696
N 2_704
N 2_788
N 2_1061
N 2_1085
N 2_1121
N 2_1145
N 2_1160
N 2_1181
N 3_4
N 3_48
N 3_61
N 3_109
N 3_136
N 3_152
N 3_221
N 3_269
N 3_318
N 3_330
N 3_590
N 3_603
N 3_644
N 3_696
N 3_704
N 3_788
N 3_1061
N 3_1085
N 3_1121
N 3_1145
N 3_1160
N 3_1181
O 1_310
O 1_312
O 2_310
O 2_312
O 3_310
O 3_312
Related Record Type Details
LIGAND->TARGET
INHIBITOR -> TARGET
BINDING
INHIBITOR -> TARGET
BINDING
LIGAND->TARGET
Binding studies have demonstrated that ADG20 competes with ACE-2 for binding to SARS-CoV-2 S protein thus preventing viral entry
VECTOR->EXPRESSED PROTEIN
INHIBITOR -> TARGET
BRII-198 has no or moderately reduced binding activity (approximately two to three-fold) to human Fc receptors (FcR I, FcR IIa, FcR IIb, FcR IIIa.
BINDING
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL